Herman PM, Craig BM, Caspi O.Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complement Altern Med. 2005;5:11.
2.
Astin JA, Shapiro SL, Eisenberg DM, Forys KLMind-body medicine: state of the science, implications for practice . J Am Board Fam Pract.2003;16:131-147.
3.
Lang EV, Rosen MPCost analysis of adjunct hypnosis with sedation during outpatient interventional radiologic procedures. Radiology. 2002;222:375-382.
4.
MacBurney M. , Young LS, Ziegler TR, Wilmore DWA cost-evaluation of glutamine-supplemented parenteral nutrition in adult bone marrow transplant patients. J Am Diet Assoc. 1994;94:1263-1266.
5.
Herman PM, Szczurko O., Cooley K., Mills EJCost-effectiveness of naturopathic care for chronic low back pain . Altern Ther Health Med. 2008;14:32-39.
6.
Fuhr JP Jr , He H., Goldfarb N., Nash DBUse of chromium picolinate and biotin in the management of type 2 diabetes: an economic analysis. Dis Manag . 2005;8:265-275.
7.
Montgomery GH , Bovbjerg DH, Schnur JB, et al. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst. 2007;99:1304-1312.
8.
Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun MJCancer statistics, 2009. CA Cancer J Clin.2009;59:225-249.
9.
Basic report. http://swz.salary.com/salarywizard/layouthtmls/swzl_compresult_national_hc07000207.html. Accessed April 15, 2010.
10.
Dimeo F., Bertz H., Finke J., Fetscher S., Mertelsmann R., Keul J.An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant . 1996;18:1157-1160
11.
Battaglini CL, Hackney AC, Garcia R., Groff D., Evans E., Shea T.The effects of an exercise program in leukemia patients. Integr Cancer Ther . 2009;8:130-138.
12.
Candrilli S. , Mauskopf J.How much does a hospital day cost?http://www.rtihs.org/request/index.cfm?fuseaction=display&PID=6465. Accessed March 12, 2010.
13.
Exercise bikes: reviews. http://www.consumersearch.com/exercise-bike-reviews. Accessed March 12, 2010.
14.
Belcaro G., Cesarone MR, Genovesi D., et al. Pycnogenol may alleviate adverse effects in oncologic treatment . Panminerva Med. 2008;50:227-234.
15.
Orlando L., Colleoni M., Nolè F., et al. Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?Ann Oncol . 2000;11:117-118.
16.
Weiss RB, Tormey DC, Holland JF, Weinberg VEVenous thrombosis during multimodal treatment of primary breast carcinoma . Cancer Treat Rep. 1981;65:677-679.
17.
Heit JACancer and venous thromboembolism: scope of the problem. Cancer Control. 2005;12(suppl 1):5-10.
18.
Mandalà M., Barni S., Floriani I., et al. Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the "GISCAD-alternating schedule" study findings. Eur J Cancer. 2009 ;45:65-73.
19.
Mandalà M., Barni S., Prins M., et al. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol. 2010;21:871-876.
20.
Fotopoulou C. , duBois A., Karavas AN, et al. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. J Clin Oncol.2008;26:2683-2689.
21.
Yildiz R., Buyukberber S., Uner A., et al. Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens. Cancer Invest. 2010;28:33-37.
22.
Spyropoulos AC, Lin J.Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm. 2007;13: 475-486.
23.
Khorana AA, Streiff MB, Farge D., et al. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol. 2009;27:4919-4926.
24.
Glynn RJ, Ridker PM, Goldhaber SZ, Zee RYL, Buring JEEffects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women’s Health Study. Circulation. 2007116: 1497-1503.
25.
DeVol R. , Bedroussian A.An unhealthy America: the economic burden of chronic disease-charting a new course to save lives and increase productivity and economic growth. http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=resrep . Accessed May 2, 2010.
